Landscapes / Targets

HER3

19 drugs act on HER3, in 121 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs19

DrugHow it worksCompanyStageNext dateDetails
Monoclonal antibody
Approved 31 Dec 2026Phase 2 trial completes
EGFR/HER3 bispecific antibody-drug conjugate
Sichuan Baili (Biokin, SystImmune) +1 · Public BMY
Phase 3 Nov 2026soonPhase 3 trial completes
—
Phase 3 Nov 2026soonPhase 2 trial completes
—
Phase 3 Nov 2026soonPhase 2 trial completes
HER3-targeted antibody-drug conjugate
Hengrui · Public 600276.SS
Phase 3 Dec 2026Phase 3 trial completes
—
Phase 3 30 Jun 2027Phase 2 trial completes
HER3-targeted antibody-drug conjugate
Daiichi Sankyo +1 · Public MRK
Phase 3 9 May 2028Phase 1/2 trial completes
—
Innovent · Public 1801.HK
Phase 1/2 30 Jun 2027Phase 1/2 trial completes
—
Phase 1/2 Jul 2027Phase 1/2 trial completes
—
Junshi Biosciences · Public 1877.HK
Phase 2 30 Nov 2027Phase 2 trial completes
—
CSPC · Public 1093.HK
Phase 2 30 Nov 2027Phase 2 trial completes
—
Phase 1/2 1 Dec 2027Phase 1/2 trial completes
—
Phase 1/2 30 Dec 2027Phase 1/2 trial completes
—
Phase 1/2 Apr 2028Phase 1/2 trial completes
—
Phase 2 —
SIBP-03not checked
—
Phase 2 —
—
Huadong Medicine · Public 000963.SZ
Phase 1 15 Apr 2027Phase 1 trial completes
—
Phase 1 1 Jul 2028Phase 1 trial completes
—
Phase 1 —

About this list

Checked
18 of 19 drugs. The other 1 is marked “not checked” in the list. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow HER3

Following is part of Solo: you see every change to HER3 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in